About
Profile
Our corporate responsibility approach is aligned with our company’s focus on invention, and underscores our commitment to overcoming the greatest obstacles to health and well-being, developing and rewarding our employees, protecting the environment, and
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
MRK
Shares added 1% on news that the pharmaceutical company has signed a $2-billion deal to develop, manufacture and commercialize China-based Hansoh Pharmas obesity drug. Merck will pay $112 million for the rights.
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Merck trades higher as Keytruda, Gardasil drive Q1 growth amid COVID pill decline
- Merck Non-GAAP EPS of $1.40 beats by $0.03, revenue of $14.48B beats by $660M
- Democratic senators introduce bill to enhance CMS drug price negotiations
- Pfizer, BioNTech hit new 52-week lows
- Merck, AstraZeneca dip as FDA reviews cancer drug ahead of AdCom meeting
- Will the Keytruda wave buoy Merck's Q1 results once again?
- EU publishes proposed reforms for pharma industry
- Bipartisan agreement reached in Senate prescription drug price legislation
- What is behind biotech M&A resurgence?
- Catalyst watch: Earnings blitz, Mobileye lockup expiration and the new one-day VIX debut
- Earnings Week Ahead: Amazon, Meta Platforms, Alphabet, Coca-Cola, Boeing, and more
- Prometheus soars 70%, Merck dips after ~$11B buyout deal
- Prometheus Biosciences had other bidders besides Merck - report
- Moderna, Merck post detailed Phase 2 data for mRNA cancer shot in melanoma
- Merck inks ~$11B all-cash deal to acquire Prometheus
- Merck said to be close to acquiring Prometheus Biosciences - WSJ
- Ghana 1st in world to approve new malaria vaccine by Oxford
- Hot Stocks: PGR drops on earnings; CNSL rises on buyout offer; MRK higher on analyst upgrade; EDIT gains; HOG slides
- Merck upgraded at Citi despite Keytruda patent cliff
- Merck's Keytruda combo gets FDA review for initial therapy in gastric, esophagus cancer
Earnings History
| Date | EPS / Forecast | Revenue / Forecast | |
|---|---|---|---|
| February 3, 2022 | 1.8 / 1.52 | 13.52B / 13.14B |
Beat! |
| October 28, 2021 | 1.75 / 1.55 | 13.15B / 12.32B |
Beat! |
| July 29, 2021 | 1.31 / 1.31 | 11.4B / 11.08B |
Beat! |
| April 29, 2021 | 1.33 / 1.53 | 12.08B / 12.61B | |
| February 4, 2021 | 1.32 / 1.38 | 12.51B / 12.67B | |
| October 27, 2020 | 1.74 / 1.44 | 12.55B / 12.21B |
Beat! |
| July 31, 2020 | 1.37 / 1.06 | 10.87B / 10.4B |
Beat! |
| April 28, 2020 | 1.5 / 1.34 | 12.06B / 11.48B |
Beat! |
| February 5, 2020 | 1.16 / 1.15 | 11.87B / 11.98B | |
| October 29, 2019 | 1.51 / 1.24 | 12.4B / 11.64B |
Beat! |
| July 30, 2019 | 1.3 / 1.16 | 11.76B / 10.96B |
Beat! |
| April 30, 2019 | 1.22 / 1.05 | 10.82B / 10.47B |
Beat! |
| February 1, 2019 | 1.04 / 1.04 | 11B / 10.94B |
Beat! |
| October 25, 2018 | 1.19 / 1.14 | 10.79B / 10.89B | |
| July 27, 2018 | 1.06 / 1.03 | 10.47B / 10.28B |
Beat! |
| May 1, 2018 | 1.05 / 1 | 10.04B / 10.09B | |
| February 2, 2018 | 0.98 / 0.94 | 10.43B / 10,494M | |
| October 27, 2017 | 1.11 / 1.03 | 10.33B / 10,545M | |
| July 28, 2017 | 1.01 / 0.87 | 9.93B / 9,746M |
Beat! |
| May 2, 2017 | 0.88 / 0.83 | 9.43B / 9,250M |
Beat! |
| Date | Price | Open | High | Low | Vol | Change | |||
|---|---|---|---|---|---|---|---|---|---|
| Jan 29 | 98.28 | 97.42 |
99.15
|
97.39
|
10.2M | 0.85% | |||
| Jan 28 | 97.45 | 97.35 |
98.88
|
96.59
|
12.8M | -0.5% | |||
| Jan 27 | 97.94 | 96.63 |
98.62
|
95.98
|
15.1M | 2.50% | |||
| Jan 24 | 95.55 | 96.79 |
97.1
|
95.4
|
12.2M | -1.12% | |||
| Jan 23 | 96.63 | 96.11 |
97.15
|
95.22
|
11.5M | 0.99% | |||
| Jan 22 | 95.68 | 95.96 |
97
|
95.15
|
13.1M | -0.58% | |||
| Jan 21 | 96.24 | 98.08 |
98.27
|
95.76
|
17.8M | -1.72% | |||
| Jan 17 | 97.92 | 100.47 |
100.47
|
97.92
|
16.2M | -2.76% | |||
| Jan 16 | 100.7 | 100.44 |
100.89
|
99.95
|
7.7M | 0.61% | |||
| Jan 15 | 100.09 | 100.1 |
100.82
|
99.61
|
9.2M | 0.44% | |||
| Jan 14 | 99.65 | 101.26 |
101.49
|
99.01
|
10.9M | -1.32% | |||
| Jan 13 | 100.98 | 99.46 |
101.16
|
98.99
|
8.2M | 1.74% | |||
| Jan 10 | 99.25 | 99.21 |
100.4
|
98.81
|
11.3M | -0.6% | |||
| Jan 8 | 99.85 | 100.7 |
100.77
|
98.05
|
8.7M | -1.16% | |||
| Jan 7 | 101.02 | 100.13 |
102.97
|
100.05
|
10.9M | 1.30% | |||
| Jan 6 | 99.72 | 98.77 |
100.33
|
98.42
|
10.1M | 0.59% | |||
| Jan 3 | 99.14 | 99.34 |
99.75
|
98.69
|
6.1M | -0.03% | |||
| Jan 2 | 99.17 | 100.28 |
100.35
|
98.83
|
6.2M | -0.31% | |||
| Dec 31, 2024 | 99.48 | 98.5 |
99.53
|
98.43
|
6.6M | 1.13% | |||
| Dec 30, 2024 | 98.37 | 99.57 |
99.57
|
98.27
|
6.8M | -1.33% | |||
| Dec 27, 2024 | 99.7 | 99.5 |
100.35
|
99.24
|
6.2M | -0.17% | |||
| Dec 26, 2024 | 99.87 | 99.09 |
99.94
|
98.92
|
4.8M | 0.42% | |||
| Dec 24, 2024 | 99.45 | 99.22 |
99.64
|
98.79
|
3.7M | 0.08% | |||
| Dec 23, 2024 | 99.37 | 99.09 |
99.59
|
98.2
|
8.5M | 1.35% | |||
| Dec 20, 2024 | 98.05 | 98.83 |
99.68
|
97.9
|
29.3M | -1.48% | |||
| Dec 19, 2024 | 99.52 | 98.56 |
99.93
|
97.82
|
12.1M | 1.20% | |||
| Dec 18, 2024 | 98.34 | 100.19 |
101.5
|
98.27
|
12.0M | -1.72% | |||
| Dec 17, 2024 | 100.06 | 99.9 |
100.8
|
99.36
|
14.0M | 0% | |||
| Dec 16, 2024 | 100.06 | 101.25 |
102.28
|
100.05
|
11.7M | -1.9% | |||
| Dec 13, 2024 | 102 | 101.13 |
102.57
|
100.53
|
10.1M | 0.74% | |||
| Dec 12, 2024 | 101.25 | 101.69 |
103
|
100.12
|
9.6M | 1.50% | |||
| Dec 11, 2024 | 99.75 | 100.7 |
101.45
|
99.26
|
21.6M | -1.24% | |||
| Dec 10, 2024 | 101 | 103.77 |
103.77
|
100.74
|
11.4M | -2.69% | |||
| Dec 9, 2024 | 103.79 | 102.86 |
105.07
|
102.33
|
19.2M | 0.68% | |||
| Dec 6, 2024 | 103.09 | 103.61 |
103.94
|
102.69
|
11.5M | -0.44% | |||
| Dec 5, 2024 | 103.55 | 101.49 |
104.14
|
101.35
|
11.1M | 2.15% | |||
| Dec 4, 2024 | 101.37 | 102.03 |
102.09
|
101.05
|
11.3M | -0.47% | |||
| Dec 3, 2024 | 101.85 | 100.75 |
102.45
|
100.62
|
11.4M | 1.23% | |||
| Dec 2, 2024 | 100.61 | 101.73 |
101.85
|
100.46
|
13.7M | -1.01% | |||
| Nov 29, 2024 | 101.64 | 102.88 |
103.04
|
101.53
|
6.1M | -1.44% | |||
| Nov 27, 2024 | 103.12 | 101.65 |
103.45
|
101.64
|
9.8M | 1.48% | |||
| Nov 26, 2024 | 101.62 | 101.48 |
101.8
|
99.7
|
9.3M | 0.45% | |||
| Nov 25, 2024 | 101.16 | 100.08 |
101.74
|
99.51
|
34.7M | 2% | |||
| Nov 22, 2024 | 99.18 | 100.33 |
101.79
|
98.93
|
14.0M | -0.68% | |||
| Nov 21, 2024 | 99.86 | 97.72 |
100.48
|
96.95
|
15.7M | 2.48% | |||
| Nov 20, 2024 | 97.44 | 96.98 |
98.84
|
96.66
|
12.1M | 0.93% | |||
| Nov 19, 2024 | 96.54 | 96.73 |
97.55
|
95.26
|
13.1M | -0.02% | |||
| Nov 18, 2024 | 96.56 | 96.56 |
97.29
|
95.42
|
14.1M | 0.26% | |||
| Nov 15, 2024 | 96.31 | 97.92 |
97.92
|
94.48
|
16.5M | -2.08% | |||
| Nov 14, 2024 | 98.36 | 99.18 |
99.4
|
97.95
|
8.7M | -0.14% | |||
| Nov 13, 2024 | 98.5 | 98.51 |
99.45
|
97.9
|
8.9M | -0.08% | |||
| Nov 12, 2024 | 98.58 | 100.76 |
100.77
|
98.5
|
12.3M | -2.13% | |||
| Nov 11, 2024 | 100.73 | 102.53 |
103.4
|
100.46
|
10.1M | -2.13% | |||
| Nov 8, 2024 | 102.92 | 101.48 |
103.23
|
101
|
9.2M | 1.73% | |||
| Nov 7, 2024 | 101.17 | 101.44 |
101.69
|
100.85
|
8.7M | 0.44% | |||
| Nov 6, 2024 | 100.73 | 103.18 |
103.23
|
100.6
|
9.6M | -0.91% | |||
| Nov 5, 2024 | 101.65 | 101.36 |
101.73
|
100.52
|
6.7M | -0.22% | |||
| Nov 4, 2024 | 101.87 | 102 |
102.53
|
100.94
|
9.2M | -0.01% | |||
| Nov 1, 2024 | 101.88 | 101.78 |
102.72
|
101.21
|
10.2M | -0.43% | |||
| Oct 31, 2024 | 102.32 | 100.93 |
103.23
|
98.6
|
17.4M | 0% | |||